Table 2.
Total number of rapid review submissions received at the National Centre for Pharmacoeconomics during the 6-year period 2012–2017
| Year | Orphan (non-cancer) | Orphan (cancer) | Ultra-orphan | Total |
|---|---|---|---|---|
| 2012 | 3 | 2 | 0 | 26 |
| 2013 | 2 | 3 | 0 | 38 |
| 2014 | 5 | 4 | 1 | 54 |
| 2015 | 4 | 4 | 3 | 44 |
| 2016 | 3 | 4 | 3 | 51 |
| 2017 | 4 | 7 | 3 | 67 |
| Total | 21 (7.5%) | 24 (8.6%) | 10 (3.6%) | 280 (100%) |